N03AX21 • retigabine • Nervous system | Antiepileptics | Other antiepileptics
Retigabine is a medication used as an adjunctive treatment for partial epileptic seizures in adult patients. It works by activating potassium channels in the brain, reducing neuronal excitability and thereby preventing seizures.
The medication is taken orally, usually in tablet form, and should be used as directed by your doctor. It is important not to abruptly stop the treatment, as this may worsen seizures.
Side effects may include drowsiness, dizziness, blurred vision, or difficulty concentrating. In rare cases, severe adverse effects such as changes in skin or eye color may occur, requiring immediate medical attention.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as kidney or liver diseases, to ensure the safe use of retigabine.
Substance: retigabine
Date of last drug list: 01-07-2015
Commercial code: W57384001
Concentration: 50mg / 100mg
Pharmaceutical form: tablets
Quantity: 63
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).